Inhibition of HIV-1 infection by human α-defensin-5, a natural antimicrobial peptide expressed in the genital and intestinal mucosae.
Inhibition of HIV-1 infection by human α-defensin-5, a natural antimicrobial peptide expressed in the genital and intestinal mucosae.
复制标题
DOI:
10.1371/journal.pone.0045208
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Lusso P
中科院分区:
文献类型:
--
作者:
Furci L;Tolazzi M;Sironi F;Vassena L;Lusso P
α-defensin-5 (HD5) is a key effector of the innate immune system with broad anti-bacterial and anti-viral activities. Specialized epithelial cells secrete HD5 in the genital and gastrointestinal mucosae, two anatomical sites that are critically involved in HIV-1 transmission and pathogenesis. We previously found that human neutrophil defensins (HNP)-1 and -2 inhibit HIV-1 entry by specific bilateral interaction both with the viral envelope and with its primary cellular receptor, CD4. Despite low amino acid identity, human defensin-5 (HD5) shares with HNPs a high degree of structural homology. Here, we demonstrate that HD5 inhibits HIV-1 infection of primary CD4+ T lymphocytes at low micromolar concentration under serum-free and low-ionic-strength conditions similar to those occurring in mucosal fluids. Blockade of HIV-1 infection was observed with both primary and laboratory-adapted strains and was independent of the viral coreceptor-usage phenotype. Similar to HNPs, HD5 inhibits HIV-1 entry into the target cell by interfering with the reciprocal interaction between the external envelope glycoprotein, gp120, and CD4. At high concentrations, HD5 was also found to downmodulate expression of the CXCR4 coreceptor, but not of CCR5. Consistent with its broad spectrum of activity, antibody competition studies showed that HD5 binds to a region overlapping with the CD4- and coreceptor-binding sites of gp120, but not to the V3 loop region, which contains the major determinants of coreceptor-usage specificity. These findings provide new insights into the first line of immune defense against HIV-1 at the mucosal level and open new perspectives for the development of preventive and therapeutic strategies.
登录
查看更多内容
影响因子:
3.4
作者:
Hickey, D. K.;Patel, M. V.;Fahey, J. V.;Wira, C. R.
通讯作者:
Wira, C. R.
DOI:
10.1111/j.1600-0897.2007.00561.x
发表时间:
2008-01-01
影响因子:
3.6
作者:
Cole, Alexander M.;Cole, Amy Liese
通讯作者:
Cole, Amy Liese
影响因子:
16.8
作者:
Appay, V;Rowland-Jones, SL
通讯作者:
Rowland-Jones, SL
DOI:
10.1126/science.1175868
发表时间:
2009-11-20
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Chen L;Kwon YD;Zhou T;Wu X;O'Dell S;Cavacini L;Hessell AJ;Pancera M;Tang M;Xu L;Yang ZY;Zhang MY;Arthos J;Burton DR;Dimitrov DS;Nabel GJ;Posner MR;Sodroski J;Wyatt R;Mascola JR;Kwong PD
通讯作者:
Kwong PD
影响因子:
3.4
作者:
Davis, HE;Rosinski, M;Yarmush, ML
通讯作者:
Yarmush, ML